India has committed US$ 85 million to the World Health Organization (WHO) to facilitate the operationalization and expansion of the WHO Global Centre for Traditional Medicine (GCTM). This disbursement represents a significant phase of a larger US$ 250 million investment pledge made by the Indian government in 2022. The funding is specifically earmarked for the center’s immediate workplan, the procurement of interim facilities, and the long-term construction of a permanent headquarters.
The financial injection is designed to bolster the WHO’s capacity to regulate, standardize, and integrate traditional medicine into global healthcare frameworks. By providing the necessary capital for infrastructure and administration, India is ensuring that the GCTM moves from a conceptual framework to a functional global entity.
The Scope of the Investment
The US$ 85 million commitment is not a general grant but is tied to specific operational milestones. According to the WHO, these funds will be utilized across three primary pillars: the execution of the center’s strategic workplan, the securing of interim premises to allow for immediate activity, and the eventual construction of a dedicated permanent building.
The GCTM is tasked with a broad mandate: to provide a centralized hub for the study of traditional medicine, ensure the safety and efficacy of traditional practices through scientific validation, and create a global repository of traditional medical knowledge. The funding allows the WHO to recruit specialized personnel and establish the technical infrastructure required to analyze diverse medical traditions from across the globe.
Why This Matters
The establishment of the GCTM marks a shift in how the world’s primary health authority views non-allopathic medicine. For decades, traditional medicine was often relegated to the periphery of global health policy, frequently viewed as complementary or anecdotal rather than clinical. This investment signals a move toward the formal institutionalization of these practices.
For the WHO, the center provides a mechanism to address the “evidence gap” that has historically hindered the integration of traditional medicine into national health systems. By creating a standardized methodology for evaluating traditional treatments, the WHO aims to protect patients from unsafe practices while identifying effective treatments that can be scaled globally.
For India, the significance is both cultural and geopolitical. India is the primary custodian of several major traditional systems, most notably Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homeopathy (collectively known as AYUSH). By funding the global center, India is not merely supporting a WHO initiative; it is actively shaping the global standards by which these systems will be judged and implemented.
Background and Context
The roots of this initiative lie in India’s domestic policy of promoting AYUSH as a viable alternative and complement to modern medicine. The Indian government has invested heavily in the Ministry of AYUSH to modernize traditional practices and promote them as “wellness” exports.
The 2022 pledge of US$ 250 million was a landmark agreement between the Government of India and the WHO, establishing a partnership that blends sovereign funding with international oversight. This partnership reflects a growing global trend where member states seek to integrate indigenous knowledge into the WHO’s “Universal Health Coverage” (UHC) goals.
Traditional medicine is utilized by millions of people worldwide, particularly in Asia and Africa, often as the first or only point of care. However, the lack of a centralized, evidence-based regulatory body has led to inconsistencies in quality control and a lack of standardized dosing and administration. The GCTM is intended to solve these systemic issues by applying rigorous scientific scrutiny to traditional pharmacopeias.
Analysis: Strategic Institutionalization and Soft Power
The scale of India’s financial contribution reflects a strategic effort to institutionalize traditional medicine within a global regulatory framework. By funding the infrastructure and the workplan of the WHO Global Centre, India is positioning its traditional healthcare systems—such as Ayurveda and Yoga—as central components of international health discourse.
This move suggests a push to move traditional medicine from the periphery of global health toward a standardized, evidence-based integration within the WHO’s broader health agendas. From a strategic perspective, this is an exercise in “health diplomacy.” By becoming the primary benefactor of the GCTM, India gains significant influence over the definitions, standards, and validation processes that will govern traditional medicine globally.
Furthermore, this investment challenges the Western-centric hegemony of medical science. By leveraging the WHO’s prestige, India is attempting to validate non-Western medical epistemologies on a global stage. If the WHO certifies specific traditional practices as evidence-based, it opens massive international markets for AYUSH-related products and services, transforming traditional knowledge into a standardized global commodity.
However, this integration carries inherent tensions. The process of “standardizing” traditional medicine often requires stripping away the holistic or spiritual contexts in which these practices evolved to fit the narrow parameters of clinical trials. There is a risk that in the pursuit of WHO certification, the nuanced, individualized nature of traditional healing may be lost to a “one-size-fits-all” pharmaceutical model.
What to Watch Next
As the GCTM becomes operational, several key indicators will determine its success and influence:
1. The Selection of Standards: Observers should monitor which traditional practices are prioritized for validation. Whether the center focuses heavily on Indian systems or maintains a broad, multi-regional approach will indicate the extent of India’s influence over the center’s agenda.
2. Regulatory Integration: The critical test will be whether WHO-validated traditional medicines are actually adopted into the national health guidelines of other member states, particularly in Europe and North America.
3. The Evidence Threshold: The specific scientific benchmarks the GCTM sets for “evidence” will be pivotal. If the thresholds are too low, the center risks being viewed as a vehicle for pseudoscience; if they are too rigid, they may alienate the traditional practitioners the center seeks to organize.
4. Infrastructure Timeline: The transition from interim premises to a permanent building will serve as a barometer for the sustained commitment of the Indian government and the WHO’s ability to manage large-scale sovereign grants.
Conclusion
The commitment of US$ 85 million is more than a financial transaction; it is a foundational step in redefining the global medical landscape. By bridging the gap between ancient tradition and modern regulation, the WHO Global Centre for Traditional Medicine seeks to create a more inclusive global health architecture. For India, it is a bold assertion of cultural and scientific leadership, aiming to ensure that the wisdom of the past is not only preserved but is codified as a pillar of future global healthcare.
Sources:
WHO News (https://www.who.int/news/item/31-07-2024-india-commits-usd-85-million-to-who-global-traditional-medicine-centre)
Corrections
If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.
Story synopsis gathered from: WHO News — source
